{
  "schemaVersion" : 2,
  "registerId" : "F2010L03266",
  "instrumentNumber" : "9/2011",
  "citation" : "Statement of Principles concerning Kaposi's sarcoma No. 9 of 2011",
  "conditionName" : "Kaposi's sarcoma",
  "effectiveFrom" : "2011-01-05",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "C46"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "6(a)",
    "text" : "being infected with human herpesvirus type 8 before the clinical onset\r\nof Kaposi's sarcoma",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(b)",
    "text" : "being infected with human immunodeficiency virus before the clinical\r\nonset of Kaposi's sarcoma",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(c)",
    "text" : "receiving systemic immunosuppressive drug therapy after undergoing\r\nsolid organ or bone marrow transplantation, at the time of the clinical\r\nonset of Kaposi's sarcoma",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(d)",
    "text" : "undergoing treatment with azathioprine, cyclophosphamide,\r\nmethotrexate or mycophenolate for a continuous period of at least three\r\nmonths, within the six months before the clinical onset of Kaposi's\r\nsarcoma",
    "definedTerms" : [ ]
  }, {
    "paragraph" : "6(e)",
    "text" : "undergoing treatment with high dose corticosteroid therapy for a\r\ncontinuous period of at least three months, within the six months\r\nbefore the clinical onset of Kaposi's sarcoma",
    "definedTerms" : [ {
      "term" : "high dose corticosteroid therapy",
      "definition" : "means daily use of oral or intravenous\ncorticosteroids equivalent to at least 15 milligrams of oral prednisone"
    } ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "6(f)",
    "text" : "inability to obtain appropriate clinical management for Kaposi's\r\nsarcoma",
    "definedTerms" : [ ]
  } ]
}